Abstract:BACKGROUND:Portal vein thrombosis (PVT) used to be a contraindication for liver transplantation (LT). This obstacle has been delt with following the improvement of LT-related techniques and therapeutic approaches to thrombosis. But the effect of PVT on LT outcomes is still controversial. We reviewed retrospectively the outcome of LT patients with PVT as well as risk factors and surgical management according to PVT grades. METHODS:A total of 465 adult LTs were performed from December 2002 through December 2006. Operative findings and the result of preoperative ultrasonography and imaging were reviewed for PVT grading (Yerdel grading). Comparison of risk factors, variables associated with perioperative period and prognosis between recipients with and without PVT is based on the grades. RESULTS:In the 465 LTs, 42 were operatively confirmed to have PVT (9.0%) (19 recipients with grade 1, 14 with grade 2, 7 with grade 3, and 2 with grade 4). Increased age and treatment of portal hypertension were associated with PVT. Grade 1 or 2 PVT was treated by direct anastomosis or single thrombectomy. In grade 3 PVT patients, the donor PV was directly anastomosed to the dilated branch of the recipient portal venous system or to the distal open superior mesenteric vein through an interposition vein graft if needed. Grade 4 PVT was managed by our modified cavoportal hemitransposition technique. The comparison between PVT patients and controls showed no significant difference in operative duration and blood transfusion (P>0.05). The flow rate of the PV was lower in the PVT patients (48.881+/-12.788 cm/s) than in the controls (57.172+/-21.715 cm/s, P<0.05). The PVT patients had such postoperative complications as renal failure and PV rethrombosis (P<0.05). The 1-year survival rates in PVT and non-PVT patients were 78.6% and 76.4% respectively (P>0.05); the 3-year survival rates were 58.8% and 56.4% respectively (P>0.05). CONCLUSIONS:PVT is not contraindicated for LT if it is graded. PVT recipients may have post-transplantation complications like renal failure and PV rethrombosis, and operative difficulty and patient survival are similar to those in recipients without PVT. Development of therapeutic approaches and accumulation of experience in dealing with PVT further improve the outcomes of LT in PVT recipients.

The causes and prevention of portal vein thrombosis after the Hassab's operation

Analysis of Related Influencing Factors of Portal Vein Thrombosis After Hepatectomy

Treatment Options for Portal Hypertension in the Era of Liver Transplantation

The Reason and Treatment of Portal Vein Thrombosis in Patients with Portal Hypertension Postoperation

Clinical analysis of portal vein thrombosis in patients with liver cirrhosis

Risk Factors of Portal Vein Thrombosis after Devascularization Treatment in Patients with Liver Cirrhosis: A Nested Case-Control Study

Comparison of prevention and treatment of portal vein thrombosis between proximal splenic vein ligation followed by postoperative transcatheter anticoagulant therapy and systemic anticoagulant therapy in patients with cirrhotic portal hypertension

Portal Vein Thrombosis Can Aggravate Esophageal Variceal Bleeding After Endoscopic Variceal Ligation

Liver Transplant Recipients with Portal Vein Thrombosis:A Single Center Retrospective Study

Analysis of the Etiology of Portal Vein Thrombosis in Liver Cirrhosis Patients

Risk factor analysis for portal vein thrombosis in 591 patients with liver cirrhosis

Intraoperative management of thrombosis in liver transplant patients complicated with portal veinthrombosis

Management Experience of Portal Vein Thrombosis of Liver Transplantation

Early Prophylactic Anticoagulation via Transjugular Intrahepatic Route for Portal Vein Thrombosis after Splenectomy in Cirrhotic Portal Hypertension

Clinical characteristics and predictors of benign portal vein thrombosis in patients with liver cirrhosis: A retrospective single-center study

Etiology and management of portal vein thrombosis：recent progress in research

Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study

Liver transplantation in adults with portal vein thrombosis: Data from the China Liver Transplant Registry.

Clinical analysis of surgical treatment of portal hypertension.

Long-term results of vascular stent placements for portal vein stenosis following liver transplantation

Management experience of portal vein thrombosis in 77 liver transplantation cases